ALS has changed the way I do everyday tasks. While I had to adopt some changes quickly — like giving up my driving privileges and no longer preparing meals — others crept in over time, like changes to the clothes I wear and my handwriting. What I found interesting,…
Discussion
People with a history of atherosclerotic cardiovascular disease (ASCVD) may have a higher risk of developing amyotrophic lateral sclerosis (ALS), while those with better cardiovascular health may have a lower risk, a large study suggests. Among more than 500,000 people from the U.K. who were followed for nearly 14…
Discussion
Common viral infections such as influenza and COVID-19 may accelerate the onset and progression of amyotrophic lateral sclerosis (ALS), a new mouse study suggests. “In our pre-clinical models, just one viral infection was enough to significantly accelerate ALS progression, even after the infection itself had resolved,” Art Marzok, PhD,…
Discussion
The amyotrophic lateral sclerosis (ALS) community is mourning Brooke Eby, an ALS advocate who documented her life with the disease on social media and helped build an online community for people living with ALS. Eby died Thursday, Oct. 1, at age 37. Eby was diagnosed with ALS in…
Discussion
For many people living with rare neuromuscular diseases, the most meaningful part of a recent Chicago gathering was not just the medical updates — it was finding a community that understood their daily struggles. The realization that they were not alone set the tone for MDA Engage: Chicago, a…
Discussion
While a bond of mutual affection can define friendship, the truest of friends share more than that. These types of friends are irreplaceable and more embedded in our lives and hearts than others. Deep friendship requires each friend to call upon the other for help and support, even in the…
Discussion
Medicinova has completed the last patient visit in the placebo-controlled portion of the COMBAT-ALS clinical trial, which is evaluating its investigational oral therapy MN-166 (ibudilast) in people with amyotrophic lateral sclerosis (ALS). The Phase 2b/3 trial (NCT04057898) is testing MN-166’s safety and efficacy at slowing disease…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Becoming educated and informed about ALS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ALS journey.
There is no cure for ALS yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
